SCHEMBL21136807

SCHEMBL21136807

CC1CN(c2c(NC=O)cnc3c(F)c(Br)c(Cl)cc23)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
MAP4K4 O95819 1/20 0.39
SUV39H2 Q9H5I1 2/20 0.37
NTRK1 P04629 4/20 0.36
CYP8B1 Q9UNU6 2/20 0.33
KAT6A Q92794 1/20 0.32
KAT8 Q9H7Z6 1/20 0.32
CHRM1 P11229 1/20 0.32
KRAS P01116 1/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
EGFR P00533 2/20 0.31
SRC P12931 1/20 0.31
DRD2 P14416 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21136711 0.87 MAPK8 (0.41) GPR119MAPT
SCHEMBL24425025 0.86 MAP4K4 (0.40) HDAC1GPR119MAP4K4SUV39H2EGFR
SCHEMBL26243059 0.86 MAP4K4 (0.40) HDAC1GPR119MAP4K4SUV39H2EGFR
SCHEMBL21137480 0.85 MAP4K4 (0.40) HDAC1GPR119MAP4K4SUV39H2NTRK1
SCHEMBL21136903 0.84 ALDH1A1 (0.40) HDAC1GPR119MAP4K4SUV39H2NTRK1
SCHEMBL18128606 0.80 MAP4K4 (0.47) HDAC1GPR119MAP4K4SUV39H2KRAS
SCHEMBL31658145 0.80 MAP4K4 (0.47) HDAC1GPR119MAP4K4SUV39H2KRAS
SCHEMBL24425024 0.79 MAP4K4 (0.40) HDAC1GPR119MAP4K4SUV39H2NTRK1
SCHEMBL28842032 0.79 MAP4K4 (0.40) HDAC1GPR119MAP4K4SUV39H2NTRK1
SCHEMBL25099624 0.77 MAP4K4 (0.43) HDAC1GPR119MAP4K4SUV39H2NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed